✦ LIBER ✦

Treatment of alkylating resistant multiple myeloma with vincristine, BCNU, doxorubicin and prednisone (VBAP)

✍ Scribed by Bladé, Joan; Rozman, Ciril; Montserrat, Emili; Cervantes, Francisco; Feliu, Evarist; Grañena, Albert; Marín, Pedro; Nomdedeu, Benet

Book ID: 123155501
Publisher: Elsevier Science
Year: 1986
Weight: 487 KB
Volume: 22
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(86)90320-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of melphalan-resistant multipl

Treatment of melphalan-resistant multiple myeloma with vincristine, BCNU, doxorubicin, and high-dose dexamethasone (VBAD)

✍ Bladé, Joan; Miguel, Jesús San; Sanz-Sanz, Miguel Angel; Alcalá, Antonio; Hernán 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 540 KB

Combination chemotherapy of multiple mye

Combination chemotherapy of multiple myeloma with Alkeran, Cytoxan, vincristine, prednisone, and BCNU

✍ Burton J. Lee; George Sahakian; Bayard D. Clarkson; Irwin H. Krakoff 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

Thirty-six patients with myeloma have been treated with a combination drug protocol (M2) including Alkeran, Cytoxan, prednisone, BCNU, and vincristine. Thirty-two patients have been adequately treated and evaluated. Sixty percent have had excellent subjective and objective responses (I-A), An additi

Improved survival times in multiple myel

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol

✍ Delvyn C. Case Jr.; Burton J. Lee III; Bayard D. Clarkson 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Comparison of oral melphalan, CCNU, and

Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and leukemia group B experience

✍ Gibbons G. Cornwell III; Thomas F. Pajak; Shaul Kochwa; O. Ross McIntyre; Linda 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

Bolus therapy with mitoxantrone and vinc

Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma

✍ Finn Wislsff; Peter Gimsing; Michael Hedenus; Erik Hippe; Ilmari Palva; Ingebrig 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

Clinical Benefits and Economic Analysis

Clinical Benefits and Economic Analysis of Pegylated Liposomal Doxorubicin/Vincristine/Dexamethasone Versus Doxorubicin/Vincristine/Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

✍ Porter, Christopher A.; Rifkin, Robert M. 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 139 KB